RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,549,453 | +39.0% | 1,725,167 | 0.0% | 0.07% | +42.0% |
| Q2 2023 | $28,448,004 | -20.9% | 1,725,167 | -14.4% | 0.05% | -36.7% |
| Q1 2023 | $35,964,833 | -44.8% | 2,015,966 | -9.9% | 0.08% | -68.7% |
| Q4 2022 | $65,178,190 | +56.0% | 2,238,262 | +31.3% | 0.25% | +86.7% |
| Q3 2022 | $41,773,000 | +571.1% | 1,705,000 | +13.7% | 0.14% | +694.1% |
| Q2 2022 | $6,225,000 | +756.3% | 1,500,000 | +5900.0% | 0.02% | +325.0% |
| Q4 2017 | $727,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |